Molecular mechanisms affecting fibrin structure and stability.
about
New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolismStaphylococcus aureus secretes coagulase and von Willebrand factor binding protein to modify the coagulation cascade and establish host infectionsFibrin-based biomaterials: modulation of macroscopic properties through rational design at the molecular level.Evaluation of thrombolysis by using ultrasonic imaging: an in vitro study.Fast two-dimensional bubble analysis of biopolymer filamentous networks pore size from confocal microscopy thin data stacks.Blood Accessibility to Fibrin in Venous Thrombosis is Thrombus Age-Dependent and Predicts Fibrinolytic Efficacy: An In Vivo Fibrin Molecular Imaging Study.Abnormal plasma clot structure and stability distinguish bleeding risk in patients with severe factor XI deficiency.Lytic resistance of fibrin containing red blood cells.Update on venous thromboembolism: risk factors, mechanisms, and treatments.Common FXIII and fibrinogen polymorphisms in abdominal aortic aneurysms.Increased plasma clot permeability and susceptibility to lysis are associated with heavy menstrual bleeding of unknown cause: a case-control study.Association between Fibrinogen and Carotid Atherosclerosis According to Smoking Status in a Korean Male Population.An Enzyme from Aristolochia indica Destabilizes Fibrin-β Amyloid Co-Aggregate: Implication in Cerebrovascular Diseases.Synthetic Strategies for Engineering Intravenous Hemostats.Aβ delays fibrin clot lysis by altering fibrin structure and attenuating plasminogen binding to fibrin.Influence of Interleukin-1 Beta on Platelet-Poor Plasma Clot Formation: A Potential Impact on Early Bone Healing.Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinkingFibrin-loaded porous poly(ethylene glycol) hydrogels as scaffold materials for vascularized tissue formation.Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.Lipoprotein (a): truly a direct prothrombotic factor in cardiovascular disease?Relationship between plasma fibrinogen levels and pulmonary function in the japanese population: the Takahata study.Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk.Fibrinogen and red blood cells in venous thrombosis.Transfusion medicine in trauma patients: an update.New developments in the area of factor XIII.Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid.Remodeling and Repair in Rhinosinusitis.Fibrinogen, red blood cells, and factor XIII in venous thrombosis.Minimal factor XIII activity level to prevent major spontaneous bleeds.Newly-Recognized Roles of Factor XIII in Thrombosis.Halting hemorrhage with self-propelling particles and local drug delivery.Structural properties of fracture haematoma: current status and future clinical implications.Fibrin Formation, Structure and Properties.Engineering fibrin polymers through engagement of alternative polymerization mechanisms.Prothrombotic Fibrin Clot Phenotype in Patients with Deep Vein Thrombosis and Pulmonary Embolism: A New Risk Factor for Recurrence.Clinical phenotype, laboratory features and genotype of 35 patients with heritable dysfibrinogenaemia.Oxidation of proteins: is it a programmed process?Platelets stored at 4°C contribute to superior clot properties compared to current standard-of-care through fibrin-crosslinking.Histologic features of acute thrombi retrieved from stroke patients during mechanical reperfusion therapy.Impact of fibrinogen carbamylation on fibrin clot formation and stability.
P2860
Q26786574-B2D9E120-4A2C-49C3-AAEE-DBE29A14DA27Q26858947-3D44F28A-E357-4D46-A186-94409FEA7B70Q27003215-E484C297-2DCD-4151-A1DD-7D1503254DC8Q30407307-160E314B-F65D-4CA6-BFA8-ED47F4304FABQ30597163-4C5C3634-AF9D-49C5-AE54-9C10BB3CD9DFQ30670224-68FE25EF-8FC7-40BA-801F-947929DBF1BEQ33934481-B022A069-AFF3-4AF0-BF09-5CE1D1B2EA62Q33954228-9886F5B9-0593-4144-85B1-F69103AE5E20Q34603017-2DCEFD83-D991-442C-B3DD-E2814752AA4EQ35407463-EB83EC1B-4786-4090-BB00-5D58B8F7DCD8Q35535747-E905F5C0-4103-4018-B919-8FAC658A5F34Q35778283-DD7A804B-B3C9-4B69-B882-A295C155F189Q35834455-A4978F4F-8CC6-4C00-B7E3-727CB0B59D1BQ35858739-F0D93678-1D9F-42EB-AAA8-C3EEC7846E71Q35876959-A3B6C816-774D-453D-93CB-84A387009552Q35933749-5266D9C1-CA4F-41E9-9E5D-F8269E6449EBQ36169271-219BF0B2-5540-494D-B427-21E98E273CA3Q36490825-05C56E8E-F0DB-47BA-8429-E38E610A5BDDQ36819410-2EC81911-01F4-4D9D-96E6-73AADD2D3B0EQ36843336-E5F17949-67B1-4064-ABE3-F6E7331D94ADQ37176968-E0D3F5FC-0B12-4B4C-AC60-6511E9F7FDB2Q37692590-6CF0E9A3-D656-499A-8FF8-35EAB8C4F649Q37730948-ED25D62B-4A1C-4A91-BC32-2FB56A151D87Q37937042-5AF84715-BAB7-4E08-8166-3CE8B30E390CQ38070913-D0234103-AD1F-46F3-859A-012D6EAC12B3Q38248477-7FF1CB5A-A77F-4914-AD9B-C4D004230CF1Q38542580-20B8A25A-B5C6-41CF-BC6F-9D7CFF40223AQ38543294-08967C62-2D14-4532-A048-48BDCAF641E0Q38688608-AE5153DE-4144-4A11-8CF4-2D01E6A60B23Q38801273-C63AEB21-5A9A-43CB-A9EF-BF53A7A9B623Q38840359-FF22D3C2-5C06-48DF-91EA-3EAE8A4D1540Q38843077-219C12E5-B272-4F88-816A-B5ED99FBB7C6Q39013217-3337F211-7710-4958-A969-3BB4117F58CEQ42159357-4D582AF9-AA93-4595-8235-538A0F7022ACQ42332549-9166A77F-0FB3-4C71-8CB5-89B974FE9E61Q45242472-9DBA3B72-5431-4AC5-848A-D29A1AFE19F2Q47249169-19167465-A0D8-483F-A724-9B4E05A2DF82Q48330143-34D934EF-2ACE-4CE8-8FD0-FD23ABCD91BBQ50203011-8F4B408E-293B-4502-853F-E3D9F3CCC03CQ50321197-938E66F7-35AE-476F-8C98-468A8ADF20EB
P2860
Molecular mechanisms affecting fibrin structure and stability.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Molecular mechanisms affecting fibrin structure and stability.
@ast
Molecular mechanisms affecting fibrin structure and stability.
@en
Molecular mechanisms affecting fibrin structure and stability.
@nl
type
label
Molecular mechanisms affecting fibrin structure and stability.
@ast
Molecular mechanisms affecting fibrin structure and stability.
@en
Molecular mechanisms affecting fibrin structure and stability.
@nl
prefLabel
Molecular mechanisms affecting fibrin structure and stability.
@ast
Molecular mechanisms affecting fibrin structure and stability.
@en
Molecular mechanisms affecting fibrin structure and stability.
@nl
P2860
P1476
Molecular mechanisms affecting fibrin structure and stability.
@en
P2093
Susan T Lord
P2860
P304
P356
10.1161/ATVBAHA.110.213389
P407
P577
2011-03-01T00:00:00Z